AIMEDBIO Funding: $67M Raised, Growth (2025)

AIMEDBIO funding overview

AIMEDBIO is based in Seoul, South Korea. AIMEDBIO has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in June 2025. The round record for AIMEDBIO runs through 2025; nothing later has been disclosed. Investors on record include Intervest, DS Asset Management, Samsung Life Insurance Foundation, SMB Investment Partners, Mirae Asset Securities. 5 distinct backers are named across the disclosed rounds.

AIMEDBIO at a glance

Total raised: $67M
Latest round: Growth
Latest round date: June 2025
Headquarters: Seoul, South Korea
Notable investors: Intervest, DS Asset Management, Samsung Life Insurance Foundation, SMB Investment Partners, Mirae Asset Securities

Frequently asked about AIMEDBIO funding

How much has AIMEDBIO raised?: AIMEDBIO has raised $67M in total disclosed funding across the rounds on record.
Who has invested in AIMEDBIO?: Intervest, DS Asset Management, Samsung Life Insurance Foundation, SMB Investment Partners, Mirae Asset Securities are named among the investors backing AIMEDBIO.
What was the latest AIMEDBIO funding round?: The most recent disclosed round is a Growth, announced in June 2025.
Where is AIMEDBIO based?: AIMEDBIO is based in Seoul, South Korea.
When did AIMEDBIO last raise?: The last disclosed AIMEDBIO round closed in June 2025 at Growth.

We update the AIMEDBIO record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Seoul and their backers are listed below.

AIMEDBIO Funding: $67M Raised, Growth (2025)

AIMEDBIO funding overview

AIMEDBIO at a glance

Frequently asked about AIMEDBIO funding

Companies related to AIMEDBIO (24)

Browse related funding lists (6)